Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Voprosy Onkologii
|
January 1, 1981
[Effect of the type of anesthesia on the long-term results of surgical treatment of lung cancer patients]
R I Vagner, I A Frid, A I Evtiukhin, et al.
Voprosy Onkologii
|
January 1, 1984
[Blood prolactin level of breast and endometrial cancer patients during surgical intervention]
V V Pozdniakov, Iu F Bobrov, V B Gamaiunova, et al.
Diabetes, Obesity & Metabolism
|
September 19, 2012
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
M Nauck, A Frid, K Hermansen, et al.
Journal of Surgical Oncology
|
March 1, 1984
Anaesthesia and development of some experimental tumours
I A Frid, A I Evtjukhin, M I Bernstein, et al.
Voprosy Onkologii
|
January 1, 1989
[Effects of hyperbaric oxygenation on tumor growth]
I A Frid, I A Sapov, A V Katyshev, et al.
Diabetes & Metabolism
|
October 12, 2010
The Third Injection Technique Workshop in Athens (TITAN)
A Frid, L Hirsch, R Gaspar, et al.
Diabetes & Metabolism
|
October 12, 2010
New injection recommendations for patients with diabetes
A Frid, L Hirsch, R Gaspar, et al.
Diabetes, Obesity & Metabolism
|
November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
J Jendle, M A Nauck, D R Matthews, et al.
Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections
|
January 4, 2014
Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors
E E Khirazova, M V Maslova, E S Motorykina, et al.
Bioorganicheskaia Khimiia
|
April 28, 2006
[The synthesis of immunomodulating peptide alloferon, the active component of the antiviral drug allokine-alpha]
M V Sidorova, A S Molokoedov, E V Kudriavtseva, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Voprosy Onkologii
|
January 1, 1981
[Effect of the type of anesthesia on the long-term results of surgical treatment of lung cancer patients]
R I Vagner, I A Frid, A I Evtiukhin, et al.
Voprosy Onkologii
|
January 1, 1984
[Blood prolactin level of breast and endometrial cancer patients during surgical intervention]
V V Pozdniakov, Iu F Bobrov, V B Gamaiunova, et al.
Diabetes, Obesity & Metabolism
|
September 19, 2012
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
M Nauck, A Frid, K Hermansen, et al.
Journal of Surgical Oncology
|
March 1, 1984
Anaesthesia and development of some experimental tumours
I A Frid, A I Evtjukhin, M I Bernstein, et al.
Voprosy Onkologii
|
January 1, 1989
[Effects of hyperbaric oxygenation on tumor growth]
I A Frid, I A Sapov, A V Katyshev, et al.
Diabetes & Metabolism
|
October 12, 2010
The Third Injection Technique Workshop in Athens (TITAN)
A Frid, L Hirsch, R Gaspar, et al.
Diabetes & Metabolism
|
October 12, 2010
New injection recommendations for patients with diabetes
A Frid, L Hirsch, R Gaspar, et al.
Diabetes, Obesity & Metabolism
|
November 26, 2009
Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue
J Jendle, M A Nauck, D R Matthews, et al.
Doklady Biological Sciences : Proceedings of the Academy of Sciences of the USSR, Biological Sciences Sections
|
January 4, 2014
Effects of single intranasal administration of obestatin fragments on the body weight and feeding and drinking behaviors
E E Khirazova, M V Maslova, E S Motorykina, et al.
Bioorganicheskaia Khimiia
|
April 28, 2006
[The synthesis of immunomodulating peptide alloferon, the active component of the antiviral drug allokine-alpha]
M V Sidorova, A S Molokoedov, E V Kudriavtseva, et al.
Page
of 8